Nippon Shinyaku Co., Ltd.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NPPNY research report →
Price Chart
About the company
Nippon Shinyaku Co. , Ltd. manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally.
- CEO
- Toru Nakai
- IPO
- 2016
- Employees
- 2,309
- HQ
- Kyoto, KY, JP
Get TickerSpark's AI analysis on NPPNY
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $1.44B
- P/E
- 7.19
- PEG
- 2.14
- P/S
- 1.26
- P/B
- 0.77
- EV/EBITDA
- 3.57
- Div Yield
- 3.68%
- Gross Margin
- 65.32%
- Op Margin
- 18.52%
- Net Margin
- 17.51%
- ROE
- 11.17%
- ROIC
- 8.82%
Latest fiscal year · YoY change
- Revenue
- $181.07B+13.0%
- Gross Profit
- $120.14B+10.1%
- Op Income
- $35.03B
- Net Income
- $31.51B-3.2%
- EPS
- $116.64-3.5%
- OCF Growth
- -20.1%
- FCF Growth
- -21.6%
- 52W High
- $15.21
- 52W Low
- $5.03
- 50D MA
- $5.67
- 200D MA
- $7.13
- Beta
- -0.32
- RSI (14)
- 36
- Avg Volume
- 111
No earnings-call transcripts are available for NPPNY yet.
- Free Float
- 23.3%
- Shares Outstanding
- 269.60M
- Float Shares
- 62.73M
Congressional trading
Senate and House stock disclosures for NPPNY, newest first.
| Member | Type | Traded | |
|---|---|---|---|
| Daniel GoldmanHouse · NY10 | Sell | Feb 27, 23 | Filing → |
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Our NPPNY coverage
Recent articles, reports, and earnings notes.
No research on NPPNY yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate NPPNY report →